Latest filing published 04 Nov 2026 for Beta Bionics, Inc., €5,596.
Filing timeline
BuySaleInsider track record
Mark Hopman: trading record in brief
Mark Hopman is a declared insider of Beta Bionics, Inc., with filings sourced from SEC (Form 4). Between 27 February 2025 and 2 November 2026, the trades on record add up to 29 filings.
On the market, this insider has only sold: 23 sales, €2.6M in total. Besides market trades, the filings include 2 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 16 sales.
The latest filing, published on 4 November 2026, reports an open-market sale of €5,596 in Beta Bionics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Hopman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 370 shares@ US$16.90Common StockSEC:0002048497-26-000025:0
- 821 shares@ US$20.000.0014% mcap0.5% of flowCommon StockSEC:0002048497-26-000023:0
- 775 shares@ US$17.350.0015% mcap0.6% of flowCommon StockSEC:0002048497-26-000021:0
- 370 shares@ US$18.960.0007% mcap0.3% of flowCommon StockSEC:0002048497-26-000018:0
- 35,994 shares@ US$18.46280.073% mcap28.5% of flowCommon StockSEC:0002048497-26-000016:0
- 30,779 shares@ US$20.13190.068% mcap26.8% of flowCommon StockSEC:0002048497-26-000015:0
- 775 shares@ US$15.520.0013% mcap0.5% of flowCommon StockSEC:0002048497-26-000014:0
- 36,870 shares@ US$18.46280.072% mcap21.7% of flowCommon StockSEC:0002048497-26-000013:0
- 5,327 shares@ US$19.11310.0095% mcap3.3% of flowCommon StockSEC:0002048497-26-000012:0
- 1,258 shares@ US$15.00830.8% of flowCommon StockSEC:0002048497-26-000009:0
- 275 shares@ US$12.310.0004% mcap0.1% of flowCommon StockSEC:0002048497-26-000008:0
- 5,329 shares@ US$12.60712.9% of flowCommon StockSEC:0002048497-26-000007:0
- 2,061 shares@ US$30.662.0% of flowCommon StockSEC:0002048497-26-000004:1
- 856 shares@ US$29.33591.1% of flowCommon StockSEC:0002048497-26-000004:0
- 353 shares@ US$11.570.2% of flowCommon StockSEC:0002048497-26-000002:0
- 834 shares@ US$12.360.3% of flowCommon StockSEC:0002048497-26-000001:1
- 109,105 shares0Common StockSEC:0002048497-26-000001:0
- 4,093 shares@ US$5.100.7% of flowCommon StockSEC:0001415889-25-023899:1
- 6,818 shares@ US$19.974.3% of flowCommon StockSEC:0001415889-25-023899:2
- 11,411 shares@ US$5.101.9% of flowCommon StockSEC:0001415889-25-023899:3
- 11,411 shares@ US$20.567.5% of flowCommon StockSEC:0001415889-25-023899:4
- 656 shares@ US$5.100.1% of flowCommon StockSEC:0001415889-25-023899:0
- 848 shares@ US$18.86320.7% of flowCommon StockSEC:0001415889-25-023743:0
- 16,158 shares@ US$16.618.6% of flowCommon StockSEC:0001415889-25-022540:1
- 16,158 shares@ US$5.103.6% of flowCommon StockSEC:0001415889-25-022540:0
25 of 29 declarations
